QuantumScape Corporation header image

QuantumScape Corporation

QS

Equity

ISIN US74767V1098 / Valor 58478497

New York Stock Exchange, Inc (2024-09-16)
USD 5.88-1.18%

QuantumScape Corporation
UMushroom community rating:

star star star star star
1.50 2 votes No rating yet
NegativeNeutralPositive

About company

QuantumScape Corporation is focused on revolutionizing energy storage, particularly in the transportation sector, by developing advanced lithium-ion batteries that address key limitations such as battery life, charging speed, and cost. Founded in 2010, the company has spent a decade developing a technology that enables fast charging, long-lasting, and safer batteries to power zero-emissions transportation. Their mission is to drive the transition towards a decarbonized future by providing innovative solutions for energy storage in the transportation industry.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (14.08.2024):

Revenue

QuantumScape Corporation reported its financial results for the second quarter of 2024, revealing that the company did not generate any revenue during this period. The focus remains on the development and commercialization of its solid-state battery technology.

Net Loss

For the second quarter of 2024, QuantumScape Corporation reported a GAAP net loss of $123.0 million. This loss reflects the company's ongoing investments in research and development as well as general and administrative expenses.

Operating Expenses

QuantumScape Corporation's operating expenses for Q2 2024 totaled $134.5 million. This includes significant expenditures on research and development, which amounted to $97.7 million, and general and administrative expenses of $36.7 million.

Liquidity

As of the end of the second quarter of 2024, QuantumScape Corporation had $938 million in liquidity. This strong liquidity position is expected to support the company's operations and capital expenditures as it moves towards higher-volume production of its QSE-5 prototype batteries.

Capital Expenditures

QuantumScape Corporation's capital expenditures for Q2 2024 were $18.9 million. These expenditures were primarily directed towards equipment purchases for low-volume QSE-5 prototype production and preparations for higher-volume production anticipated in 2025.

Summarized from source with an LLMView Source

Key figures

-15.2%1Y
-72.4%3Y
%5Y

Performance

74.6%1Y
82.4%3Y
105%5Y

Volatility

Market cap

2645 M

Market cap (USD)

Daily traded volume (Shares)

733,982

Daily traded volume (Shares)

1 day high/low

5.96 / 5.83

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

1.50

2 votes
Performance:
starstarstarstarstar
2.00
Innovation:
starstarstarstarstar
3.00
Society:
starstarstarstarstar
3.00
Nature:
starstarstarstarstar
3.00
Daniela Gie
Germany, 20 Jun 2024
star star star star star
Possible fraud https://scorpioncapital.s3.us-east-2.amazonaws.com/reports/QS1.pdf
Tej Ram Kumpakha
Switzerland, 22 Mar 2022
star star star star star
They develops effective and efficient solid-state lithium-metal batteries for use in electric vehicles. Upcoming expansion plans to meet the demand of batteries electric vehicles.

EQUITIES OF THE SAME SECTOR

Veracyte Inc
Veracyte Inc Veracyte Inc Valor: 22423969
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.16%USD 33.63
Koninklijke Philips NV
Koninklijke Philips NV Koninklijke Philips NV Valor: 1106818
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.47%EUR 27.70
Cisco Systems Inc
Cisco Systems Inc Cisco Systems Inc Valor: 918546
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.47%USD 51.03
Ascendis Pharma
Ascendis Pharma Ascendis Pharma Valor: 26912602
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
17.07%USD 139.57
KK RAKUS
KK RAKUS KK RAKUS Valor: 30340556
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.45%JPY 2,244.50
KK Hitachi Seisakusho
KK Hitachi Seisakusho KK Hitachi Seisakusho Valor: 761899
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.32%JPY 3,431.00
Von Roll Holding Ltd
Von Roll Holding Ltd Von Roll Holding Ltd Valor: 324535
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.95%CHF 0.85
Molecular Partners Ltd
Molecular Partners Ltd Molecular Partners Ltd Valor: 25637909
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.48%CHF 4.38
argenx SE
argenx SE argenx SE Valor: 24766616
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.51%EUR 485.50
Melexis NV
Melexis NV Melexis NV Valor: 723330
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.87%EUR 75.90